Age-specific involutive characteristics of cognitive functions

Аннотация

The review article reflects the specific features of involutive cognitive functions in elderly people. Furthermore the basis of these changes is the natural physiological process of morphofunctional remodeling of the human body in general and of the central nervous system in particular. As a result, the elderly and senium people have cognitive decline, and in the presence of provoking medical and social factors and comorbid diseases they may have transient cognitive dysfunction.

Conflict of Interest: nothing to disclose.

Список литературы

1. Zakharov BB, Yakhno HH. [Cognitive disorders in the elderly and senile age]. Moscow. 2005. (InRuss.).

2. Zakharov VV, Voznesenskaya TG. [Neuropsychiatric disorders: diagnostic tests]. M., MEDpress-inform, 2013.(InRuss.).

3. Levin OS. [Diagnosis and treatment of dementia in clinical practice]. M., MEDpress-inform, 2010.(InRuss.).

4. Levin OS. [Cognitive impairment in neurologist practice]. M., MEDpress-inform, 2006. (In Russ.).

5. Batty GD, Der G, Macintyre S, Deary IJ.Does IQ explain socioeconomic inequalities in health? Evidence from a population based cohort study in the west of Scotland. BMJ. Mar 11,2006;332(7541): 580–584.doi: 10.1136/bmj.38723.660637.AE

6. Putilina MV. [Modern ideas about nootropic drugs]. LechaschijVrach.2006;5:10–14. (InRuss.).

7. Akai F, Hiruma S. Neurotrophic factor-like effect of FPF 1070 on septal cholinergic neurons after transactions of fimbria-fornix in the rat brain. Histol. Histopathol. 1992;7:213–21.

8. Rumyantsev SA, Stupin VA, Oganov RG, et al. [Theory and practice of treatment of patients with vascular comorbidity]. M–SPb., Meditsinskaya kniga,2013. (In Russ.).

9. Gomazkov OA. [Neurotrophic and growth factors of the brain: regulatory specificity and therapeutic potential].Uspekhifiziologicheskikhnauk.2005;36(2):1–25. (InRuss.).

10. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia and major subtypes of dementia. Mayo. Clin. Proc. 2003;78:1290–1308.PMID: 14531488 doi: 10.4065/78.10.1290

11. Damulin IV. [Alzheimer's disease and vascular dementia]. Ed. Yakhno NN. M., 2002. (In Russ.).

12. Kalin JB, Gavrilova SI. [Social factors and mental disorders in elderly and senile age]. Ed. DmitrievaTB. M.: Medicine, 2001. (InRuss.).

13. Levin OS. [Diagnosis and treatment of moderate cognitive impairment in the elderly]. JournalofNeurologyandPsychiatry.2006;8:42–49. (InRuss.).

14. Suslina ZA, Varakin YuA, Vereshchagin NV. [Vascular brain disease]. M.: MEDpress-inform, 2006. (InRuss.).

15. Vercambre MN, et al. Physical activity and cognition in women with vascular conditions. Arch. Intern. Med. 2011;171(14):1244–1250.doi: 10.1001/archinternmed.2011.282

16. Slobodin TA, Goreva AV. [Cognitive reserve: causes of decline and defense mechanisms]. International neurological journal. 2012;3:161–165. (In Russ.). 

17. Zakharov VV, Jahno NN. [Memory Disorders]. M.: GEOTAR-Media, 2003. (InRuss.).

18. Ivanchuk EG, Orujev YaS. [Features of mental and cognitive disorders in the liquidators of the Chernobyl accident (clinic, diagnosis, treatment)]. Volgograd. 2009. (InRuss.).

19. Coffey CEWilkinson WEParashos IA, et al.Quantitative cerebral anatomy of the aging human brain. Neurology. 1992;42:527–536.PMID: 1549213 doi: 10.1212/wnl.42.3.527

20. Cherrier MM, Matsumoto AM, Amory JK, et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64:2063–2068.

21. Silverman D, Alavi A. PET imaging in the assessment of normal and impaired cognitive function. Radiol. Clin. N.Am. 2005;43:67–77.

22. Skoromets AA [Neurotransmitters in brain aging: the key to understanding memory and attention disorders]. Moscow. 2005. (InRuss.).

23. Zakharov VV, Yakhno NN. [Syndrome of moderate cognitive disorders in the elderly: diagnosis and treatment]. Russian Medical Journal.2004;10:573–576. (InRuss.).

24. Bennett DA. Mild cognitive impairment. Clin. Geriatr. Med.2004;20:15–25.

25. Budson AE, Price BH. Memory dysfunction. NEJM. 2005;352:692–699.doi: 10.1056/NEJMra041071

26. Velichkovsky BB. Possibilities of cognitive training as a method of correction of age-related disorders of cognitive control. Experimentalpsychology. 2009;3:78–91. (InRuss.).

27. Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015–2028.

28. Tucker AM, Stern Y. Cognitive reserve in aging. Current Alzheimer research. 2011;8(4):354–360.

29. Scarmeas N, Stern Y. Cognitive reserve and lifestyle. J. Clin. Exp. Neuropsychol. 2003;25(5):625–633.

30. Vercambre MN, et al. Physical activity and cognition in women with vascular conditions. Arch. Intern. Med. 2011;171(14):1244–1250.

31. Yakhno NN. [Cognitive impairment in a neurological clinic]. Neurologicaljournal. 2006;11:4–12. (InRuss.).

Для цитирования

SimerzinVV, FatenkovOV, PanishevaYaA, GalkinaMA, GagloevAV. Age-specific involutive characteristics of cognitive functions. Science & Innovations in Medicine. 2019;4(2):21-26. DOI: 10.35693/2500-1388-2019-4-2-21-26

Request

Send an online application form to the publication

Send